Results 11 to 20 of about 17,901 (223)
Pentoxifylline for intermittent claudication [PDF]
Медицинский совет, 2015 Obliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication.
N. A. Vaulin
doaj +6 more sources
Cilostazol for intermittent claudication [PDF]
Cochrane Database of Systematic Reviews, 2014 Peripheral arterial disease (PAD) affects between 4% and 12% of people aged 55 to 70 years, and 20% of people over 70 years. A common complaint is intermittent claudication (exercise-induced lower limb pain relieved by rest). These patients have a three- to six-fold increase in cardiovascular mortality.
Brown, Tamara +5 more
openaire +8 more sources
Increasing walking in patients with intermittent claudication: Protocol for a randomised controlled trial [PDF]
BMC Cardiovascular Disorders, 2010 Background People with intermittent claudication are at increased risk of death from heart attack and stroke compared to matched controls. Surgery for intermittent claudication is for symptom management and does not reduce the risk of cardiovascular ...
O'Carroll Ronan E +3 more
doaj +2 more sources
Eccentric strength and endurance in patients with unilateral intermittent claudication [PDF]
Clinics, 2009 OBJECTIVE: To analyze concentric and eccentric strength and endurance in patients with unilateral intermittent claudication. INTRODUCTION: Basic motor tasks are composed of concentric, isometric, and eccentric actions, which are related and contribute to
Márcio Basyches +5 more
doaj +2 more sources
Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication [PDF]
Biomedicines, 2023 Intermittent claudication is a frequent complaint in lower extremity artery disease, but approximately two thirds of patients are asymptomatic, most of which are diabetic patients. Non-invasive angiological and microrheological tests on diabetic subjects
Katalin Biró +8 more
doaj +2 more sources
Biomarker Analysis from the Compass Claudication Study – Rivaroxaban for Intermittent Claudication [PDF]
Clinical and Applied Thrombosis/HemostasisIntroduction A prospective, randomized, multicenter study compared rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily against aspirin 100 mg once daily alone in patients with peripheral artery disease and intermittent claudication.
Karen Falcão Britto MD +19 more
doaj +2 more sources
BMC Cardiovascular Disorders, 2009 Background Disease severity and functional impairment in patients with intermittent claudication is usually quantified by the measurement of pain-free walking distance (intermittent claudication distance, ICD) and maximal walking distance (absolute ...
Prins Martin H +5 more
doaj +2 more sources
Remote ischemic preconditioning in patients with intermittent claudication [PDF]
Clinics, 2013 OBJECTIVE: Remote ischemic preconditioning (RIPC) is a phenomenon in which a short period of sub-lethal ischemia in one organ protects against subsequent bouts of ischemia in another organ.
Glauco Fernandes Saes +9 more
doaj +2 more sources
Current Management of Intermittent Claudication [PDF]
Advances in Surgery, 2023 David P Stonko, Caitlin W Hicks
exaly +2 more sources
Effects of intermittent claudication due to arterial disease on pain-free gait [PDF]
, 2021 Studies of intermittent claudication gait report inconsistent outcomes. Changes in gait are often attributed to degradation of calf muscles, but causation has not been proven through real-time electromyographic data. Neither have effects of walking speed
Boyd, Peter +9 more
core +1 more source